Home News Astra’s Antibody Cocktail Fails to Stop Covid-19 in Study back to News
minute read
AstraZeneca Plc’s antibody cocktail was only 33% effective at preventing symptomatic Covid-19 in people who had been exposed to the virus, failing a study that was key to the drugmaker’s pandemic push.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
